AKRO
Akero Therapeutics
AKRO
AKRO
Delisted
AKRO was delisted on the 8th of December, 2025.
109 hedge funds and large institutions have $913M invested in Akero Therapeutics in 2021 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 31
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
91% less call options, than puts
Call options by funds: $2.23M | Put options by funds: $24.5M
Holders
109
Holding in Top 10
3
Calls
$2.23M
Puts
$24.5M
Top Buyers
| 1 | +$7.78M | |
| 2 | +$6.84M | |
| 3 | +$6.06M | |
| 4 |
Alkeon Capital Management
New York
|
+$6.04M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$5.55M |
Top Sellers
| 1 | -$5.76M | |
| 2 | -$5.19M | |
| 3 | -$4.64M | |
| 4 |
Renaissance Technologies
New York
|
-$3.87M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.69M |